title: Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream.
authors.forename: F
authors.initials: F
authors.lastname: Vanaclocha
authors.forename: E
authors.initials: E
authors.lastname: Daudén
authors.forename: X
authors.initials: X
authors.lastname: Badía
authors.forename: C
authors.initials: C
authors.lastname: Guillén
authors.forename: J S
authors.initials: JS
authors.lastname: Conejo-Mir
authors.forename: M
authors.initials: M
authors.lastname: Sainz de Los Terreros
authors.forename: L
authors.initials: L
authors.lastname: Hamel
authors.forename: M A
authors.initials: MA
authors.lastname: Llorens
mesh_terms: D000634:Aminoquinolines / Q000191:economics* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000191:economics* / Q000601:surgery; D003362:Cost-Benefit Analysis / Q000191:economics; D006801:Humans; D000077271:Imiquimod; D015580:Mohs Surgery / Q000191:economics*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000191:economics* / Q000601:surgery
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod